In:
BJU International, Wiley, Vol. 122, No. 1 ( 2018-07), p. 13-25
Abstract:
To identify areas of agreement and disagreement in the implementation of multi‐parametric magnetic resonance imaging (mp MRI ) of the prostate in the diagnostic pathway. Materials and Methods Fifteen UK experts in prostate mp MRI and/or prostate cancer management across the UK (involving nine NHS centres to provide for geographical spread) participated in a consensus meeting following the Research and Development Corporation and University of California‐Los Angeles ( UCLA ‐ RAND ) Appropriateness Method, and were moderated by an independent chair. The experts considered 354 items pertaining to who can request an mp MRI , prostate mp MRI protocol, reporting guidelines, training, quality assurance ( QA ) and patient management based on mp MRI levels of suspicion for cancer. Each item was rated for agreement on a 9‐point scale. A panel median score of ≥7 constituted ‘agreement’ for an item; for an item to reach ‘consensus’, a panel majority scoring was required. Results Consensus was reached on 59% of items (208/354); these were used to provide recommendations for the implementation of prostate mp MRI in the UK . Key findings include prostate mp MRI requests should be made in consultation with the urological team; mp MRI scanners should undergo QA checks to guarantee consistently high diagnostic quality scans; scans should only be reported by trained and experienced radiologists to ensure that men with unsuspicious prostate mp MRI might consider avoiding an immediate biopsy. Conclusions Our consensus statements demonstrate a set of criteria that are required for the practical dissemination of consistently high‐quality prostate mp MRI as a diagnostic test before biopsy in men at risk.
Type of Medium:
Online Resource
ISSN:
1464-4096
,
1464-410X
DOI:
10.1111/bju.2018.122.issue-1
Language:
English
Publisher:
Wiley
Publication Date:
2018
detail.hit.zdb_id:
2019983-1
